Fractyl Health, Inc. Common Stock (GUTS)
Healthcare
Biotechnology
0.68 $
-1.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Fractyl Health, Inc. Common Stock (GUTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -11 | -11 | -12 | -19 | -18 | -17 | -25 | -21 | -23 | -21 | -22 | -88 | |
| 0.1 | 0.1 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1.1 | |
| 1.1 | 1.1 | 1.3 | 5.2 | 3.8 | 2.5 | 2.9 | 1.4 | 1.8 | 1.6 | 1.9 | 2.5 | 7.8 | |
| -0.8 | -0.3 | 1.2 | 3.4 | -1.0 | 2.1 | 5.0 | -1.9 | 3.2 | -1.5 | -0.2 | -4.5 | -3.0 | |
| 0.1 | 0.1 | 0.1 | 1.1 | 0.3 | 0.2 | 0.2 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -0.1 | -0.1 | – | -1.1 | -0.3 | -0.2 | -0.2 | -0.4 | -0.1 | 0.0 | 0.0 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 0.2 | – | |
| – | – | – | – | – | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.5 | |
| 0.0 | 28 | -0.6 | 101 | 0.0 | 0.2 | 0.1 | 0.2 | 1.5 | 78 | 25 | 4.1 | 109 | |
| -12 | 17 | -11 | 88 | -19 | -18 | -17 | -25 | -20 | 55 | 3.9 | -18 | 21 | |
| -12 | -11 | -11 | -13 | -19 | -18 | -17 | -26 | -21 | -23 | -21 | -22 | -88 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.